Narcolepsy link to Glaxo vaccine poses challenge for FDA<p><a href="http://news.yahoo.com/narcolepsy-glaxo-vaccine-poses-challenge-fda-223234880--finance.html"><img src="http://l2.yimg.com/bt/api/res/1.2/ZhfdPpZcB5aPNnM4Tc9_Nw--/YXBwaWQ9eW5ld3M7Zmk9ZmlsbDtoPTg2O3E9ODU7dz0xMzA-/http://media.zenfs.com/en_us/News/Reuters/2013-03-07T223234Z_1_CBRE9261QMD00_RTROPTP_2_NARCOLEPSY-VACCINE-PANDEMRIX.JPG" width="130" height="86" alt="The first shipment of pandemic vaccine against the swine influenza A (H1N1) Pandemrix arrives in Malmo" align="left" title="The first shipment of pandemic vaccine against the swine influenza A (H1N1) Pandemrix arrives in Malmo" border="0" /></a>(Reuters) - Growing evidence of a link between GlaxoSmithKline Plc's pandemic flu vaccine and an increase in narcolepsy cases among children who received it in Europe, is giving pause to health regulators weighing approval of a similar vaccine in the United States. ...</p><br clear="all"/>
Source: Narcolepsy link to Glaxo vaccine poses challenge for FDA (http://news.yahoo.com/narcolepsy-glaxo-vaccine-poses-challenge-fda-223234880--finance.html)